Within its last year performance, CKPT rose by 42.71%, with highs and lows ranging from $4.50 to $1.38, whereas the simple moving average jumped by 9.66% in the last 200 days.
On January 13, 2025, D. Boral Capital started tracking Checkpoint Therapeutics Inc (NASDAQ: CKPT) recommending Buy. B. Riley Securities also rated CKPT shares as ‘Buy’, setting a target price of $18 on the company’s shares in an initiating report dated June 09, 2021. Cantor Fitzgerald Initiated an Overweight rating on January 20, 2021, and assigned a price target of $16. Lake Street initiated its ‘Buy’ rating for CKPT, as published in its report on May 29, 2019. H.C. Wainwright’s report from December 08, 2017 suggests a price prediction of $11 for CKPT shares, giving the stock a ‘Buy’ rating.
Analysis of Checkpoint Therapeutics Inc (CKPT)
Further, the quarter-over-quarter decrease in sales is -100.00%, showing a negative trend in the upcoming months.
One of the most important indicators of Checkpoint Therapeutics Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. Taking into account the quick ratio of the company, currently set at 0.29, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CKPT is recording 1.39M average volume. On a monthly basis, the volatility of the stock is set at 6.45%, whereas on a weekly basis, it is put at 4.23%, with a loss of -3.73% over the past seven days. Furthermore, long-term investors anticipate a median target price of $15.75, showing growth from the present price of $2.84, which can serve as yet another indication of whether CKPT is worth investing in or should be passed over.
How Do You Analyze Checkpoint Therapeutics Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 22.49%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 16.00% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CKPT shares are owned by institutional investors to the tune of 16.00% at present.
